Tag: Medtronic

Mazor X

Medtronic announces US commercial launch of Mazor X Stealth Edition

The first US patients have been treated with the Mazor X Stealth Edition (Medtronic) for spine surgery following its commercial launch. The technology offers...

Medtronic completes acquisition of Mazor Robotics

Medtronic today announced it has completed the acquisition of Mazor Robotics. The total value of the transaction is reported at US$1.7 billion, or US$1.3 billion...

Mazor Robotics shareholders approve US$1.64B Medtronic transaction

Mazor Robotics has announced that at a Special General Meeting of Shareholders held on 19 November, 2018, Mazor shareholders approved the previously announced definitive...
Concorde

Global orthopaedic devices market worth US$47.7 billion by 2026

  The "Orthopaedic devices market size, share and trends analysis report by application (hip, knee, spine, cranio-maxillofacial, dental, SET), by product (accessories, surgical devices), and segment...
robotics

Costs curbing the rise of robotics in spinal surgery

The era of routine robotic-assisted spinal surgery is on the horizon. Despite the hype, however, there remains little market penetration, with affordability and the degree...
Medtronic

Medtronic launches the Infinity OCT spinal system

Medtronic has announced the US launch of the Infinity Occipitocervical-Upper Thoracic (OCT) System designed to simplify posterior cervical spine surgery. A company press release...
market

Spinal implants market to exceed US$19.5 billion by 2024

The global spinal implants market is forecast to grow at a 7% compound annual growth rate to exceed US$19.5 billion by 2024, according to...
Medtronic Mazor

Medtronic to acquire Mazor robotics

Medtronic and Mazor Robotics have announced that the two companies have entered into a definitive merger agreement under which Medtronic will acquire all outstanding...

Bone cement solution indicated for treating sacral fractures granted FDA approval

The US Food and Drug Administration (FDA) has granted 510(k) clearance of Kyphon HV-R bone cement (Medtronic) for fixation of pathological fractures of the...

FDA approval for Infuse Bone Graft in expanded spinal surgery indications

Infuse Bone Graft (Medtronic) has gained US Food and Drug Administration (FDA) approval in new spine surgery indications. InfuseBone Graft is now approved for...

Scoliosis Research Society collaborates with corporate partners and International Spine Study...

The Scoliosis Research Society (SRS) has partnered with Globus Medical, K2M, Medtronic, NuVasive, Zimmer Biomet, and the International Spine Study Group Foundation (ISSGF) to...
Metronic Intellis

Non-opioid alternative for chronic pain approved in Europe

A Conformité Européene (CE) Mark has been received by Medtronic for its neurostimulation platform Intellis for spinal cord stimulation (SCS) and peripheral nerve stimulation...
Mazor X

CE mark for Mazor X Surgical Assurance platform

Mazor Robotics has announced CE mark approval for its Mazor X Surgical Assurance Platform. The approval allows Mazor and its commercial partner, Medtronic, to...
Metronic Intellis

US FDA approves Medtronic’s Intellis spinal cord stimulation device

The US Food and Drug Administration has approved Medtronic’s Intellis spinal cord stimulator. The company has now launched the product in the USA for...

First patient enrolled in long-term Infuse posterolateral fusion study

Medtronic has announced the launch of a long-term clinical study programme to collect prospective data on rhBMP-2 (Infuse) bone graft in posterolateral fusion (PLF)...

Medtronic revises indications for use of Navlock trackers following patient deaths

Medtronic has updated the indications for use and the warning statements for its Navlock trackers, following two patient deaths. The trackers—which are part of...

Medtronic launches most advanced StealthStation for neurosurgery

Medtronic has launched its new StealthStation technology at the American Academy of Neurological Surgeons (AANS) annual conference in Los Angeles, USA. The new S8...
Medtronic logo

Medtronic announces new US bone cement indication for treating sacral fractures

Medtronic has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance of Kyphon Xpede bone cement for fixation of pathological...

Ohio judge dismisses hundreds of off-label Medtronic Infuse patient lawsuits

US district court judge, Timothy S Black (Southern Ohio, USA) has dismissed the accusation of several hundred plaintiffs that they have been treated off-label...

Medtronic completes US$20 million second tranche investment in Mazor Robotics

Medtronic has completed the second tranche of a previously agreed equity investment in Mazor Robotics. According to a press release, the triggering milestone for this...